A shadow economy for unlicensed slimming medications is propelled by social media fitness personalities and vendors on communication apps, according to new investigations.
Experimental Drug Acquiring Traction Via Social Media
Retatrutide, which is still in research studies, is being promoted by online personalities for its supposed fat-burning properties. Followers are encouraged to contact these profiles privately for source information, while also receiving discount codes.
Thriving Commerce on Messaging Platforms
Additionally, a robust trade exists on Telegram, where communities with thousands of participants share comparison photos, administration instructions and assertions of next-day British shipping. Sellers market the drug there before redirecting customers to WhatsApp for transactions.
Learning About Retatrutide
This medication is an investigational injection developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could help patients lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.
Medical Professionals Express Concerns
Nevertheless, physicians and pharmacists have warned that the distribution of what is still an unlicensed medication in the United Kingdom is worrisome and could result in users administering substances of unknown origin.
Some professionals said the popularity for the experimental drug could be linked to the increasing price of approved weight loss products such as Mounjaro.
Regulatory Position and Enforcement
Selling the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.
Several content creators try to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still violate medicines, advertising, and customer laws, risking fines, prosecution or imprisonment.
Service Reaction and Material Removal
According to TikTok, the platform has removed problematic material and banned associated keywords and search suggestions. The organization stated it was dedicated to keeping the platform secure and investing in strengthening compliance measures.
Online Trading Operations
Research also found communities with up to 9,000 participants marketing the experimental drug using Telegram's built-in search feature, which operates like a online catalog. Entering “retatrutide” immediately brings up groups with numerous of users, filled with photos of slimming results, glowing reviews and detailed guides for preparing or injecting at home.
Within moments of entering one group, a seller posted WhatsApp details, where most transactions occur. The vendor sent an instruction manual and promised shipping within two days. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one inquired about body mass, medical conditions or previous experience.
Item Information and Costs
Inside these communities, posts show dark colored parcels with Royal Mail stickers, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at home with purified liquid, or pre-filled pens typically priced at £160 for 20mg. When asked how much time a pen should last, sellers give conflicting responses ranging from a several days to “depends on your body”.
Platform Moderation and Safety Actions
A spokesperson for Telegram stated it actively moderated harmful material on its platform including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“People are injecting substances they can’t verify. Even if the science behind this drug is sound, these online products may not contain what they advertise,” said a pharmacy expert, the head of pharmacy at a pharmacy service.
A medical professional of an online medical service connected the surge in interest to recent cost increases for approved slimming drugs such as Mounjaro. “With prices rising, patients are using social media. But counterfeit treatments are highly dangerous. You cannot know what’s inside or whether the conditions they were made in was sterile,” she said.
Her team has previously encountered individuals harmed by self-injection from unverified sources. “We recognize the frustration, but buying from messaging apps or communication platforms is gambling with your well-being,” stated Wyllie. “These substances could be impure or incorrectly dosed.”
Manufacturer Position
A representative from the pharmaceutical company stated the substance was in third stage research studies and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they explained, noting that any item “falsely representing itself as a company investigational substance not yet authorized … may subject patients to potentially serious health risks”.
